Adaptive Biotechnologies Corporation (ADPT) vs LivaNova PLC (LIVN)
A side-by-side comparison of Adaptive Biotechnologies Corporation and LivaNova PLC across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADPT
Adaptive Biotechnologies Corporation
$27.63HealthcareDelayed quote: Oct 6, 2026, 11:00 AM EDT
LIVN
LivaNova PLC
$75.42HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
Total return — ADPT vs LIVN
growth of $100 · dividends reinvested · last 7yADPT -26.0% (-4.2%/yr)LIVN +6.2% (+0.9%/yr)LIVN compounded faster over this window
ADPT LIVN
ADPT vs LIVN: by the numbers
- •ADPT is the larger company ($4.42B vs $4.14B market cap).
- •LIVN is profitable (12.82% net margin) while ADPT runs a net loss (-20.73%).
- •ADPT grew revenue faster over the past five years (18.22% vs 7.57% CAGR).
Metrics side by side
Valuation
| Metric | ADPT | LIVN |
|---|---|---|
| P/E ratio | N/A | 22.25 |
| Forward P/E | N/A | 17.32 |
| P/S ratio | 14.35 | 2.82 |
| P/B ratio | 30.94 | 3.13 |
| EV / EBITDA | N/A | 16.28 |
| FCF yield | N/A | 3.58% |
Profitability
| Metric | ADPT | LIVN |
|---|---|---|
| Gross margin | 75.44% | 68.18% |
| Operating margin | -20.62% | 13.48% |
| Net margin | -20.73% | 12.82% |
| ROE | -44.68% | 14.23% |
| ROIC | -6.67% | 10.24% |
Growth (annualized)
| Metric | ADPT | LIVN |
|---|---|---|
| Revenue CAGR (5Y) | 18.22% | 7.57% |
| FCF CAGR (5Y) | N/A | 20.23% |
| Total return CAGR (5Y) | -1.77% | -1.66% |
Frequently asked
- Which has grown faster, ADPT or LIVN?
- Over the past five years, ADPT grew revenue faster — ADPT at a 18.22% CAGR versus LIVN at 7.57%.
- Is ADPT or LIVN more profitable?
- LIVN runs the higher net margin — ADPT at -20.73% versus LIVN at 12.82%.
- How have ADPT and LIVN total returns compared?
- Over the past 5 years, ADPT delivered -1.77% and LIVN delivered -1.66% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
LivaNova P/E ratioAdaptive Biotechnologies ROELivaNova ROEAdaptive Biotechnologies operating marginLivaNova operating marginAdaptive Biotechnologies revenue growthLivaNova revenue growthAdaptive Biotechnologies free cash flowLivaNova free cash flow
Adaptive Biotechnologies & LivaNova appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.